COVID-19 Vaccination and Communicable Disease Testing Services' Integration Within a Syringe Services Program: A...

Area of Science:

• Public Health
• Infectious Disease Prevention
• Health Equity

Background:

• Individuals who inject drugs face elevated risks for severe outcomes from coronavirus disease 2019 (COVID-19).
• Barriers to healthcare access exacerbate vulnerabilities within this population.
• There is a critical need to integrate COVID-19 vaccination strategies for people who inject drugs.

Purpose of the Study:

• To describe a collaborative initiative providing integrated health services.
• To assess the effectiveness of co-locating services for people who inject drugs.
• To share lessons learned from a community-based service delivery model.

Main Methods:

• A partnership was formed between the Baltimore City Health Department, Johns Hopkins Mobile Vaccine Unit, and the Center for Infectious Disease and Nursing Innovation.
• Services including COVID-19 vaccination, HIV/STI testing, wound care, and linkage to care were co-located with a syringe services program.
• Data on service delivery and participant engagement were collected.

Main Results:

• The co-location model successfully provided essential health interventions to a vulnerable population.
• Integrated services reduced barriers to accessing COVID-19 vaccination and other critical health needs.
• The initiative demonstrated a feasible approach to reaching underserved communities.

Conclusions:

• Co-locating health services, including COVID-19 vaccination, with syringe services programs is an effective strategy.
• This model enhances healthcare access and addresses health disparities for people who inject drugs.
• Community-based partnerships are vital for successful implementation and sustained impact.